- Euromonitor International
-
-
Store
WHAT'S NEWIntroducing enhanced country reports featuring interactive datagraphics, charts and analysis.Learn More
- Countries
- Industries
- Companies
- Economies
- Consumers
- Australia
- Brazil
- Canada
- China
- Colombia
- Denmark
- Egypt
- France
- Germany
- Hong Kong
- India
- Indonesia
- Ireland
- Italy
- Japan
- Kenya
- Malaysia
- Mexico
- Netherlands
- Nigeria
- Pakistan
- Peru
- Philippines
- Poland
- Romania
- Russia
- Saudi Arabia
- Singapore
- South Africa
- South Korea
- Spain
- Switzerland
- Taiwan
- Thailand
- Turkey
- United Arab Emirates
- United Kingdom
- United States
- Vietnam
- Alcoholic Drinks
- Apparel and Footwear
- Beauty and Personal Care
- Consumer Appliances
- Consumer Electronics
- Consumer Finance
- Consumer Foodservice
- Consumer Health
- Eyewear
- Fresh Food
- Health and Wellness
- Home and Garden
- Home Care
- Hot Drinks
- Industrial/Commercial
- Ingredients
- Luxury Goods
- Mobility
- Nutrition
- Packaged Food
- Packaging
- Personal Accessories
- Pet Care
- Retailing
- Soft Drinks
- Sports
- Tissue and Hygiene
- Tobacco
- Toys and Games
- Travel
- American Express Co
- Amway Corp
- Apple Inc
- Asahi Group Holdings Ltd
- Avon Products Inc
- Beiersdorf AG
- Bristol-Myers Squibb Co
- Campari Milano SpA, Davide
- Coach Inc
- Coca-Cola Co, The
- Colgate-Palmolive Co
- Danone, Groupe
- Gap Inc, The
- H&M Hennes and Mauritz AB
- Henkel AG & Co KGaA
- Herbalife Ltd
- Inditex, Industria de Diseño Textil SA
- Inter Ikea Systems BV
- Johnson & Johnson Inc
- Kao Corp
- Kraft Foods Inc
- LG Corp
- LVMH Moët Hennessy Louis Vuitton SA
- Mars Inc
- Mondelez International Inc
- Natura Cosméticos SA
- Nestlé SA
- Nu Skin Enterprises Inc
- PepsiCo Inc
- Procter & Gamble Co, The
- Reckitt Benckiser Group Plc (RB)
- Royal FrieslandCampina NV
- Samsung Corp
- Sara Lee Corp
- Seven & I Holdings Co Ltd
- Sharp Corp
- Sony Corp
- Toyo Seikan Group Holdings, Ltd
- Unilever Group
Megatrends
The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn more
Euromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn more - Solutions
- Capabilities
- Blog
- Careers
- About Us
-
Store
Company Profile
Johnson & Johnson in Consumer Health
Nov 2019
US$570Added to Cart
New Report Guarantee
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
About This Report
New Report Guarantee
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Johnson & Johnson Inc (J&J) is the second largest company in consumer health. OTC remains its most important category, supported by its global power brands, while its presence in vitamins and dietary supplements (VDS) continues to be limited. The company relies significantly on North America, its home market, but there are significant opportunities in other regions, particularly in Asia Pacific, where Johnson & Johnson has only a small presence.
Files are delivered directly into your account within a few minutes of purchase.
Samples
Overview
Why buy this report?
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Euromonitor International's report on Johnson & Johnson Inc delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy.
Company and market share data provide a detailed look at the financial position of Johnson & Johnson Inc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Johnson & Johnson Inc.
This report examines:
- Company share by region and sector
- Brand portfolio
- New product developments
- Marketing and distribution strategies
A detailed SWOT analysis of Johnson & Johnson Inc provides strategic intelligence on:
- Strengths and weaknesses
- Category and country opportunities for growth
- Challenges and threats from current competition and future prospects
- Global and regional market positions
Research You Can Trust:
Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out.
Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
Delivery format
Reports are delivered in PDF format and can be downloaded from your online account immediately after purchase.
Want to find out more about this report?
Request more informationTable of Contents
Scope of the Report
Scope
Introduction
Executive summary
State of Play
Top companies at a glance
Johnson & Johnson’s global footprint
Company overview
Changes to Johnson & Johnson’s portfolio impact its performance
Exposure to Future Growth
The US remains Johnson & Johnson’s growth driver
Competitive Positioning
Diversification from OTC should be a key strategy
GSK/Pfizer’s post-merger portfolio creates a threat for J&J
Tylenol holds a strong position in analgesics in the US, supported by innovation
Johnson & Johnson is a major player in OTC with a diversified portfolio
Johnson & Johnson’s brands have broad coverage but limited leadership
OTC/Cough, Cold and Allergy Remedies
J&J could benefit from extending exposure in Asia Pacific
Johnson & Johnson’s product portfolio differs among its top 10 markets
Analgesics
Asia Pacific offers potential in region where J&J remains small
Greater focus on topical analgesics could be of benefit
Johnson & Johnson’s paediatric analgesics portfolio in leading markets
Key Findings
Key findings
Appendix
Projected company sales: FAQs (1)
Projected company sales: FAQs (2)
Why buy this report?
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Want to find out more about this report?
Request more informationComplete Catalogue
Company Reports
- Amway Corp in Consumer Health | Jun 2019
- Bayer AG (Merck & Co) in Consumer Health | Nov 2014
- Bayer AG in Consumer Health | Apr 2017
- Bayer in Consumer Health | Feb 2021
- Beiersdorf AG in OTC Healthcare | Aug 2009
- Boehringer Ingelheim GmbH in Consumer Health | May 2015
- Bristol-Myers Squibb Co in Consumer Health | Feb 2013
- General Nutrition Centers in Consumer Health | Nov 2018
- General Nutrition Centers Inc in Consumer Health | Mar 2013
- Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture | Sep 2014
- GlaxoSmithKline Plc in Consumer Health | Nov 2020
- GlaxosmithklinePlc in Consumer Health | Sep 2019
- Herbalife Ltd in Consumer Health | Dec 2016
- Herbalife Nutrition Ltd | Jan 2019
- Herbalife Nutrition Ltd in Consumer Health | Mar 2020
- Johnson & Johnson Inc in Consumer Health | Oct 2020
- Merck & Co Inc in Consumer Health | Jul 2013
- Merck KGaA in Consumer Health | May 2012
- NBTY Inc in Consumer Health | Sep 2013
- Novartis AG in Consumer Health | Sep 2013
- Nu Skin Enterprises Inc in Consumer Health | Aug 2011
- Otsuka Pharmaceutical Co Ltd in Consumer Health | Aug 2010
- Pfizer Inc in Consumer Health | Nov 2017
- Procter & Gamble Co, The (P&G) in Consumer Health | Jan 2020
- Procter & Gamble Co, The in Consumer Health | Oct 2015
- Reckitt Benckiser in Consumer Health | Mar 2020
- Reckitt Benckiser Plc (RB) in Consumer Health | Jul 2018
- Sanofi in Consumer Health | Oct 2020
- Sanofi-Aventis in Consumer Health | Sep 2011
- STADA Arzneimittel AG in Consumer Health | Dec 2020
- Taisho Pharmaceutical Co Ltd in Consumer Health | Sep 2011
- Takeda Pharmaceutical Co Ltd in Consumer Health | Apr 2013
Complete Catalogue
Company Reports
- Amway Corp in Consumer Health | Jun 2019
- Bayer AG (Merck & Co) in Consumer Health | Nov 2014
- Bayer AG in Consumer Health | Apr 2017
- Bayer in Consumer Health | Feb 2021
- Beiersdorf AG in OTC Healthcare | Aug 2009
- Boehringer Ingelheim GmbH in Consumer Health | May 2015
- Bristol-Myers Squibb Co in Consumer Health | Feb 2013
- General Nutrition Centers in Consumer Health | Nov 2018
- General Nutrition Centers Inc in Consumer Health | Mar 2013
- Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture | Sep 2014
- GlaxoSmithKline Plc in Consumer Health | Nov 2020
- GlaxosmithklinePlc in Consumer Health | Sep 2019
- Herbalife Ltd in Consumer Health | Dec 2016
- Herbalife Nutrition Ltd | Jan 2019
- Herbalife Nutrition Ltd in Consumer Health | Mar 2020
- Johnson & Johnson Inc in Consumer Health | Oct 2020
- Merck & Co Inc in Consumer Health | Jul 2013
- Merck KGaA in Consumer Health | May 2012
- NBTY Inc in Consumer Health | Sep 2013
- Novartis AG in Consumer Health | Sep 2013
- Nu Skin Enterprises Inc in Consumer Health | Aug 2011
- Otsuka Pharmaceutical Co Ltd in Consumer Health | Aug 2010
- Pfizer Inc in Consumer Health | Nov 2017
- Procter & Gamble Co, The (P&G) in Consumer Health | Jan 2020
- Procter & Gamble Co, The in Consumer Health | Oct 2015
- Reckitt Benckiser in Consumer Health | Mar 2020
- Reckitt Benckiser Plc (RB) in Consumer Health | Jul 2018
- Sanofi in Consumer Health | Oct 2020
- Sanofi-Aventis in Consumer Health | Sep 2011
- STADA Arzneimittel AG in Consumer Health | Dec 2020
- Taisho Pharmaceutical Co Ltd in Consumer Health | Sep 2011
- Takeda Pharmaceutical Co Ltd in Consumer Health | Apr 2013